Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gri Bio Inc (GRI)

Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gri Bio Inc 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 USA

www.gribio.com Employees: 4 P: 619-400-1170

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

GRI Bio Inc. is a clinical stage biopharmaceutical company which focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio Inc., formerly known as Vallon Pharmaceuticals Inc., is based in PHILADELPHIA, PA.

Key Statistics

Overview:

Market Capitalization, $K 810
Enterprise Value, $K -4,220
Shares Outstanding, K 3,269
Annual Sales, $ 0 K
Annual Net Income, $ -8,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,360 K
EBIT, $ -11,270 K
EBITDA, $ -9,160 K
60-Month Beta -1.48
% of Insider Shareholders 0.87%
% of Institutional Shareholders 33.95%
Float, K 3,240
% Float 99.13%
Short Interest 384
Short Float 11.73%
Short Volume Ratio 0.51

Growth:

1-Year Return -97.92%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.28 on 11/14/25
Next Earnings Date 03/13/26
Earnings Per Share ttm -8.39
EPS Growth vs. Prev Qtr 2.29%
EPS Growth vs. Prev Year 88.77%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 12/19/19
Dividend Payable Date 12/27/19
Dividend Payout Ratio 0.00%
Most Recent Split 1-17 on 02/24/25

GRI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -426.23%
Return-on-Assets % -222.24%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.35
Book Value/Share 0.79
Interest Coverage -274.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar